How Personalized Medicine Became Genetic, and Racial: Werner Kalow and the Formations of Pharmacogenetics

作者: D. S. Jones

DOI: 10.1093/JHMAS/JRR046

关键词:

摘要: Physicians have long puzzled over a well-known phenomenon: different patients respond differently to the same treatment. Although many explanations exist, pharmacogenetics has now captured medical imagination. While this might seem part of broader interest in all things genetic, early history reveals specific factors that contributed emergence genetics within pharmacology. This paper examines work one pioneering pharmacologist, Werner Kalow, trace evolving intellectual formations and, particular, focus on race. Working 1950s and 1960s, Kalow made three arguments demonstrate relevance pharmacology, based laboratory techniques, analogies differences between other animal species, appeals logic natural selection. After contributing field, maintained his advocacy for four decades, collecting more evidence its relevance, navigating controversies about race science, balancing against possible patient variability. Kalow’s demonstrates deep roots genetic racial preoccupations Understanding can restore attention individuality practice, something increasing importance given current personalized medicine.

参考文章(171)
Nancy E. Simpson, Werner Kalow, COMPARISONS OF TWO METHODS FOR TYPING OF SERUM CHOLINESTERASE AND PREVALENCE OF ITS VARIANTS IN A BRAZILIAN POPULATION. American Journal of Human Genetics. ,vol. 17, pp. 156- 162 ,(1965)
A. H. Conney, E. J. Pantuck, R. Kuntzman, A. Kappas, K. E. Anderson, A. P. Alvares, Nutrition and chemical biotransformations in man. Clinical Pharmacology & Therapeutics. ,vol. 22, pp. 707- 720 ,(1977) , 10.1002/CPT1977225PART2707
Beverley A. Britt, Werner Kalow, Alan Gordon, John G. Humphrey, N. Barry Rewcastle, Malignant hyperthermia: an investigation of five patients Canadian Journal of Anaesthesia-journal Canadien D Anesthesie. ,vol. 20, pp. 431- 467 ,(1973) , 10.1007/BF03026208
Dennis E. Drayer, Marcus M. Reidenberg, Clinical consequences of polymorphic acetylation of basic drugs Clinical Pharmacology & Therapeutics. ,vol. 22, pp. 251- 258 ,(1977) , 10.1002/CPT1977223251
B. A. Britt, W. G. Locher, W. Kalow, Hereditary aspects of malignant hyperthermia Canadian Journal of Anaesthesia-journal Canadien D Anesthesie. ,vol. 16, pp. 89- 98 ,(1969) , 10.1007/BF03005788
Ian Whitmarsh, David S. Jones, What's the use of race? : modern governance and the biology of difference MIT Press. ,(2010)
Bernard B. Brodie, Ervin G. Erdös, Metabolic factors controlling duration of drug action Symposium Publications Division, Pergamon. ,(1962)